Skip to main content

NATIXIS

Position in BSX — Boston Scientific Corp

CIK 1274981 PARIS, I0

Position in BSX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,171,776
-$26,717,177 QoQ
Shares Held
168,036
-68.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#358
of 1,468 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Dec 31, 2022
CallValue
$0
CallShares
0
PutValue
$2,956,653
PutShares
63,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

NATIXIS holds $149,303,624 across 13 Medical Devices names. BSX ranks #6 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 BSX
Boston Scientific Corp
This page
168,036 $7,171,776

All Filings in BSX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,171,776 168,036
2026-03-31 $33,888,953 540,063
2025-12-31 $52,824,948 554,011
2025-09-30 $53,273,566 545,668
2025-06-30 $52,640,137 490,086
2025-03-31 $55,735,292 552,491
2024-12-31 $47,251,530 529,014
2024-09-30 $53,297,470 636,008
2024-06-30 $36,736,080 477,030
2024-03-31 $33,433,530 488,152
2023-12-31 $40,451,506 699,732
2023-09-30 $3,803,131 72,029
2023-06-30 $4,795,240 88,653
2023-03-31 $20,294,319 405,643
2022-12-31 $2,956,653 63,900
2022-12-31 $8,932,516 193,052
2022-09-30 $4,749,731 122,637
2022-06-30 $5,601,159 150,286
2022-03-31 $26,649,160 601,697
2021-12-31 $74,740,840 1,759,436
2021-09-30 $32,914,264 758,568
2021-06-30 $18,064,688 422,467
2021-03-31 $4,523,402 117,035
2020-12-31 $9,998,449 278,121
2020-09-30 $7,614,144 199,271
2020-06-30 $1,286,360 36,638
2020-03-31 $1,477,780 45,289